2024 Journal Article [177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trialEmmett, Louise, Subramaniam, Shalini, Crumbaker, Megan, Nguyen, Andrew, Joshua, Anthony M., Weickhardt, Andrew, Lee, Sze-Ting, Ng, Siobhan, Francis, Roslyn J., Goh, Jeffrey C., Pattison, David A., Tan, Thean Hsiang, Kirkwood, Ian D., Gedye, Craig, Rutherford, Natalie K., Sandhu, Shahneen, Kumar, Aravind Ravi, Pook, David, Ramdave, Shakher, Nadebaum, David P., Voskoboynik, Mark, Redfern, Andrew D., Macdonald, William, Krieger, Laurence, Schembri, Geoff, Chua, Wei, Lin, Peter, Horvath, Lisa, Bastick, Patricia ... Davis, Ian D. (2024). [177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial. The Lancet Oncology, 25 (5), 563-571. doi: 10.1016/s1470-2045(24)00135-9 |
2024 Journal Article Plasma lipoprotein(a) is associated with calcification activity of the thoracic aorta and aortic valve in statin naïve individuals with diabetes mellitusBellinge, Jamie W., Chan, Dick C., Pang, Jing, Francis, Roslyn J., Page, Michael M., Watts, Gerald F. and Schultz, Carl J. (2024). Plasma lipoprotein(a) is associated with calcification activity of the thoracic aorta and aortic valve in statin naïve individuals with diabetes mellitus. European Journal of Clinical Investigation, 54 (5) e14167. doi: 10.1111/eci.14167 |
2024 Journal Article Evaluating the impact of FET PET on radiotherapy target volume delineation: Results of the radiation oncology credentialing program from the prospective, multi-centre trial evaluating FET PET in glioblastoma (FIG) study – TROG 18.06Barry, Nathaniel, Koh, Eng-Siew, Ebert, Martin A., Moore, Alisha, Francis, Roslyn J., Rowshanfarzad, Pejman, Mubashar Hassan, Ghulam, Ng, Sweet P., Back, Michael, Chua, Benjamin, Pinkham, Mark B, Pullar, Andrew, Phillips, Claire, Sia, Joseph, Gorayski, Peter, Le, Hien, Gill, Suki, Croker, Jeremy, Bucknell, Nicholas, Bettington, Catherine, Syed, Farhan, Jung, Kylie, Chang, Joe, Bece, Andrej, Clark, Catherine, Wada, Mori, Cook, Olivia, Whitehead, Angela, Rossi, Alana ... Scott, Andrew M. (2024). Evaluating the impact of FET PET on radiotherapy target volume delineation: Results of the radiation oncology credentialing program from the prospective, multi-centre trial evaluating FET PET in glioblastoma (FIG) study – TROG 18.06. Physics and Imaging in Radiation Oncology, 30 100568, 1-8. doi: 10.1016/j.phro.2024.100568 |
2024 Journal Article The prognostic value of F18 Fluorothymidine positron emission tomography for assessing the response of malignant pleural mesothelioma to chemotherapy – a prospective cohort studyMay, Isaac J., Nowak, Anna K., Francis, Roslyn J., Ebert, Martin A. and Dhaliwal, Satvinder S. (2024). The prognostic value of F18 Fluorothymidine positron emission tomography for assessing the response of malignant pleural mesothelioma to chemotherapy – a prospective cohort study. Journal of Medical Imaging and Radiation Oncology, 68 (1), 57-66. doi: 10.1111/1754-9485.13592 |
2024 Journal Article Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trialHofman, Michael S., Emmett, Louise, Sandhu, Shahneen, Iravani, Amir, Buteau, James P., Joshua, Anthony M., Goh, Jeffrey C., Pattison, David A., Tan, Thean Hsiang, Kirkwood, Ian D., Ng, Siobhan, Francis, Roslyn J., Gedye, Craig, Rutherford, Natalie K., Weickhardt, Andrew, Scott, Andrew M., Lee, Sze-Ting, Kwan, Edmond M., Azad, Arun A., Ramdave, Shakher, Redfern, Andrew D., Macdonald, William, Guminski, Alex, Hsiao, Edward, Chua, Wei, Lin, Peter, Zhang, Alison Yan, Stockler, Martin R., Williams, Scott G. ... Yip, Sonia (2024). Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial. The Lancet Oncology, 25 (1), 99-107. doi: 10.1016/s1470-2045(23)00529-6 |
2024 Journal Article The Australian traumatic brain injury initiative: systematic review and consensus process to determine the predictive value of demographic, injury event, and social characteristics on outcomes for people with moderate-severe traumatic brain injuryGabbe, Belinda J., Keeves, Jemma, Mckimmie, Ancelin, Gadowski, Adelle M., Holland, Andrew J., Semple, Bridgette D., Young, Jesse T., Crowe, Louise, Ownsworth, Tamara, Bagg, Matthew K., Antonic-Baker, Ana, Hicks, Amelia J., Hill, Regina, Curtis, Kate, Romero, Lorena, Ponsford, Jennie L., Lannin, Natasha A., O'brien, Terence J., Cameron, Peter A., Cooper, Jamie, Rushworth, Nick, Fitzgerald, Melinda, Alexander, Tara, Anderson, Vicki, Armstrong, Elizabeth, Babl, Franz E., Balogh, Zsolt J., Barlow, Karen M. (AUS-TBI Initiative Investigators member), Bellapart, Judith ... Honeybul, Stephen (2024). The Australian traumatic brain injury initiative: systematic review and consensus process to determine the predictive value of demographic, injury event, and social characteristics on outcomes for people with moderate-severe traumatic brain injury. Journal of Neurotrauma. doi: 10.1089/neu.2023.0461 |
2024 Journal Article The Australian traumatic brain injury initiative: systematic review and consensus process to determine the predictive value of pre-existing health conditions for people with moderate-severe traumatic brain injuryAntonic-Baker, Ana, Auvrez, Clarissa, Tao, Gerard, Bagg, Matthew K., Gadowski, Adelle, McKimmie, Ancelin, Hicks, Amelia J., Hill, Regina, Romero, Lorena, Ponsford, Jennie L., Lannin, Natasha A., Gabbe, Belinda J., Cameron, Peter A., Cooper, D. Jamie, Rushworth, Nick, Fitzgerald, Melinda, O'Brien, Terence J., Alexander, Tara, Anderson, Vicki, Armstrong, Elizabeth, Babl, Franz E., Balogh, Zsolt J., Barlow, Karen M. (AUS-TBI Initiative Investigators group member), Bellapart, Judith, Bidargaddi, Niranjan, Bosio, Erika, Bragge, Peter, Bynevelt, Michael, Caeyenberghs, Karen ... Zeeman, Heidi (2024). The Australian traumatic brain injury initiative: systematic review and consensus process to determine the predictive value of pre-existing health conditions for people with moderate-severe traumatic brain injury. Journal of Neurotrauma. doi: 10.1089/neu.2023.0462 |
2024 Journal Article The impact of fluorine-18-fluoroethyltyrosine positron emission tomography scan timing on radiotherapy planning in newly diagnosed patients with glioblastomaRyan, John, Hardcastle, Nicholas, Francis, Roslyn, Ferjančič, Peter, Ng, Sweet Ping, Koh, Eng-Siew, Geso, Moshi, Kelly, Jennifer and Ebert, Martin A. (2024). The impact of fluorine-18-fluoroethyltyrosine positron emission tomography scan timing on radiotherapy planning in newly diagnosed patients with glioblastoma. Physics and Imaging in Radiation Oncology, 29 100536, 100536. doi: 10.1016/j.phro.2024.100536 |
2023 Journal Article Quantitative [68Ga]Ga-PSMA-11 PET biomarkers for the analysis of lesion-level progression in biochemically recurrent prostate cancer: a multicentre studyKendrick, Jake, Francis, Roslyn J., Hassan, Ghulam Mubashar, Rowshanfarzad, Pejman, Ong, Jeremy S. L., Barry, Nathaniel, Rusanov, Branimir and Ebert, Martin A. (2023). Quantitative [68Ga]Ga-PSMA-11 PET biomarkers for the analysis of lesion-level progression in biochemically recurrent prostate cancer: a multicentre study. Scientific Reports, 13 (1) 17673, 17673. doi: 10.1038/s41598-023-45106-2 |
2023 Journal Article Prospective inter-and intra-tracer repeatability analysis of radiomics features in [68Ga]Ga-PSMA-11 and [18F]F-PSMA-1007 PET scans in metastatic prostate cancerKendrick, Jake, Francis, Roslyn J., Hassan, Ghulam Mubashar, Rowshanfarzad, Pejman, Ong, Jeremy S.L., Jeraj, Robert, Barry, Nathaniel, Hagan, Tammy and Ebert, Martin A. (2023). Prospective inter-and intra-tracer repeatability analysis of radiomics features in [68Ga]Ga-PSMA-11 and [18F]F-PSMA-1007 PET scans in metastatic prostate cancer. British Journal of Radiology, 96 (1152) 20221178, 1-11. doi: 10.1259/bjr.20221178 |
2023 Journal Article Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically recurrent prostate cancer from [68Ga]Ga-PSMA-11 PET imagesKendrick, Jake, Francis, Roslyn J., Hassan, Ghulam Mubashar, Rowshanfarzad, Pejman, Ong, Jeremy S. L., McCarthy, Michael, Alexander, Sweeka and Ebert, Martin A. (2023). Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically recurrent prostate cancer from [68Ga]Ga-PSMA-11 PET images. European Journal of Nuclear Medicine and Molecular Imaging, 50 (13), 4077-4086. doi: 10.1007/s00259-023-06382-2 |
2023 Journal Article Improved arterial inflammation with high dose omega-3 fatty acids in patients with elevated lipoprotein(a): selective effect of eicosapentaenoic acid?Ward, Natalie C., Ying, Qidi, Chan, Dick C., Pang, Jing, Mori, Trevor A., Schultz, Carl J., Dwivedi, Girish, Francis, Roslyn J. and Watts, Gerald F. (2023). Improved arterial inflammation with high dose omega-3 fatty acids in patients with elevated lipoprotein(a): selective effect of eicosapentaenoic acid?. Journal of Clinical Lipidology, 17 (5), 694-699. doi: 10.1016/j.jacl.2023.08.004 |
2023 Journal Article Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study—TROG 18.06Barry, Nathaniel, Francis, Roslyn J., Ebert, Martin A., Koh, Eng-Siew, Rowshanfarzad, Pejman, Hassan, Ghulam Mubashar, Kendrick, Jake, Gan, Hui K., Lee, Sze T., Lau, Eddie, Moffat, Bradford A., Fitt, Greg, Moore, Alisha, Thomas, Paul, Pattison, David A., Akhurst, Tim, Alipour, Ramin, Thomas, Elizabeth L., Hsiao, Edward, Schembri, Geoffrey P., Lin, Peter, Ly, Tam, Yap, June, Kirkwood, Ian, Vallat, Wilson, Khan, Shahroz, Krishna, Dayanethee, Ngai, Stanley, Yu, Chris ... Scott, Andrew M. (2023). Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study—TROG 18.06. European Journal of Nuclear Medicine and Molecular Imaging, 50 (13), 3970-3981. doi: 10.1007/s00259-023-06371-5 |
2023 Journal Article [18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trialKoh, Eng-Siew, Gan, Hui K., Senko, Clare, Francis, Roslyn J., Ebert, Martin, Lee, Sze Ting, Lau, Eddie, Khasraw, Mustafa, Nowak, Anna K., Bailey, Dale L., Moffat, Bradford A., Fitt, Greg, Hicks, Rodney J., Coffey, Robert, Verhaak, Roel, Walsh, Kyle M., Barnes, Elizabeth H., De Abreu Lourenco, Richard, Rosenthal, Mark, Adda, Lucas, Foroudi, Farshad, Lasocki, Arian, Moore, Alisha, Thomas, Paul A., Roach, Paul, Back, Michael, Leonard, Robyn and Scott, Andrew M. (2023). [18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial. BMJ Open, 13 (8) e071327. doi: 10.1136/bmjopen-2022-071327 |
2023 Journal Article Targeted alveo-pleural fistula endobronchial valve treatment using ventilation scintigraphySidhu, Calvin, Ratnagobal, Shoba, Thomas, Rajesh, Lee, Gary Y. C., Drudy, Enya and Francis, Roslyn J. (2023). Targeted alveo-pleural fistula endobronchial valve treatment using ventilation scintigraphy. Respirology Case Reports, 11 (5) e01146. doi: 10.1002/rcr2.1146 |
2023 Journal Article Considerations for imaging of malignant pleural mesothelioma: a consensus statement from the International Mesothelioma Interest GroupKatz, Sharyn I., Straus, Christopher M., Roshkovan, Leonid, Blyth, Kevin G., Frauenfelder, Thomas, Gill, Ritu R., Lalezari, Ferry, Erasmus, Jeremy, Nowak, Anna K., Gerbaudo, Victor H., Francis, Roslyn J. and Armato, Samuel G. (2023). Considerations for imaging of malignant pleural mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Journal of Thoracic Oncology, 18 (3), 278-298. doi: 10.1016/j.jtho.2022.11.018 |
2022 Journal Article Unravelling the role of macrophages in cardiovascular inflammation through imaging: a state-of-the-art reviewParry, Reece, Majeed, Kamran, Pixley, Fiona, Hillis, Graham Scott, Francis, Roslyn Jane and Schultz, Carl Johann (2022). Unravelling the role of macrophages in cardiovascular inflammation through imaging: a state-of-the-art review. European Heart Journal Cardiovascular Imaging, 23 (12), e504-e525. doi: 10.1093/ehjci/jeac167 |
2022 Journal Article Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [68Ga]Ga-PSMA-11 PET/CT imagesKendrick, Jake, Francis, Roslyn J., Hassan, Ghulam Mubashar, Rowshanfarzad, Pejman, Ong, Jeremy S. L. and Ebert, Martin A. (2022). Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [68Ga]Ga-PSMA-11 PET/CT images. European Journal of Nuclear Medicine and Molecular Imaging, 50 (1), 67-79. doi: 10.1007/s00259-022-05927-1 |
2022 Journal Article The effect of vitamin-K1 and colchicine on vascular calcification activity in subjects with diabetes mellitus (ViKCoVaC): a double-blind 2x2 factorial randomized controlled trialBellinge, Jamie W., Francis, Roslyn J., Lee, Sing Ching, Vickery, Alistair, Macdonald, William, Gan, Seng Khee, Chew, Gerard T., Phillips, Michael, Lewis, Joshua R., Watts, Gerald F. and Schultz, Carl J. (2022). The effect of vitamin-K1 and colchicine on vascular calcification activity in subjects with diabetes mellitus (ViKCoVaC): a double-blind 2x2 factorial randomized controlled trial. Journal of Nuclear Cardiology, 29 (4), 1855-1866. doi: 10.1007/s12350-021-02589-8 |
2022 Journal Article Event‐free survival after radical prostatectomy according to PSMA PET and EAU Biochemical Recurrence Risk GroupsRoberts, Matthew J., Chatfield, Mark D., Hruby, George, Nandurkar, Rohan, Roach, Paul, Watts, Jo Anne, Cusick, Thomas, Kneebone, Andrew, Eade, Thomas, Ho, Bao, Nguyen, Andrew, Tang, Colin, McCarthy, Michael, Francis, Roslyn, Stricker, Phillip and Emmett, Louise (2022). Event‐free survival after radical prostatectomy according to PSMA PET and EAU Biochemical Recurrence Risk Groups. BJU International, 130 (S3), 32-39. doi: 10.1111/bju.15762 |